UNSPSC 51201802: Filgrastim

This classification denotes a therapeutic colony stimulating factor with the molecular formula C845H1339N223O243S9, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier PVI5M0M1GW, more generally known as filgrastim. European Medicines Agency schedules filgrastim in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07627MIG. The term FILGRASTIM is an International Non-Proprietary Name or INN. see WHO INN reference publication, Volume 5, no. 3 1991, list 31.

UNSPSC 51201802 Filgrastim is a Commodity code for a specific pharmaceutical product — a granulocyte colony-stimulating factor used to support white blood cell production in immunocompromised patients. State and local governments procure this drug through pharmacy benefit managers, health plans, and direct purchase agreements for use in correctional facilities, public health clinics, county hospitals, and other government-operated health systems. The code sees activity across state departments of health, county health authorities, public hospital systems, and corrections agencies that manage inpatient and outpatient pharmacy inventories.

The recent opportunities block contains no procurement activity aligned with this code's scope. The single posted solicitation (Sourcewell RFP #061626, due June 16, 2026) addresses law enforcement equipment through a cooperative purchasing vehicle and does not reference pharmaceutical procurement, filgrastim, or any health-related acquisition. This mismatch suggests the code shows little relevant recent activity in state and local contracting, or that opportunities under this Commodity are posted through channels not captured in the source data.